Rhumbline Advisers Eton Pharmaceuticals, Inc. Transaction History
Rhumbline Advisers
- $105 Billion
- Q2 2024
Shares
4 transactions
Others Institutions Holding ETON
# of Institutions
47Shares Held
8.16MCall Options Held
41KPut Options Held
1K-
Opaleye Management Inc. Boston, MA2.4MShares$13.9 Million2.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.03MShares$5.96 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT941KShares$5.46 Million0.21% of portfolio
-
Westside Investment Management, Inc.585KShares$3.4 Million0.44% of portfolio
-
Acuitas Investments, LLC580KShares$3.36 Million1.08% of portfolio
About Eton Pharmaceuticals, Inc.
- Ticker ETON
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,297,000
- Market Cap $147M
- Description
- Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...